Chru Nancy
Vandœuvre-lès-Nancy, 54511, France
NCT Number: NCT04555252
Cephalic duodenopancreatectomy is part of the curative treatment for pancreatic cancer of the head and peri-ampullary area. The mortality of the procedure is around 5%, with a morbidity ranging from 30 to 50%. Infectious complications account for 35% of overall morbidity.
One of the risk factors for postoperative complications is the existence of preoperative retentional jaundice, due to tumoral obstruction of the main bile duct In these cases, it is proposed to perform preoperative bile duct drainage, preferably by endoscopic stenting (ERCP).
However, several studies have shown these procedures to cause biliary contamination which could be responsible for an increase in post-operative morbidity such as infectious complications and increased length of stay in hospital..
Thus, the biliary microbial flora is more often multi-microbial and may contain multidrug-resistant nosocomial germs,
The study carried out by Cortes et al., based on a control case study design, also showed that a correlation between biliary colonization and postoperative infectious complications existed in patients who benefited from a preoperative biliary drainage technique. In fact, the bacteria isolated during intraoperative bile sampling were similar, in 49% of cases, to those isolated during bacteriological samples collected postoperatively during infectious complications.
The work carried out by Krüger and al has shown that the spectrum of bacteria found in the preoperative bile samples from patients who have undergone bile duct dilation is potentially not covered by standard antibiotic therapy.
The aim of this observational prospective study is to investigate this correlation between biliary colonization and postoperative infectious complications, to evaluate the morbidity and postoperative mortality of cephalic duodenopancreatectomies performed at the CHRU of Nancy and to study a possible adaptation of perioperative antibiotic prophylaxis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Vandœuvre-lès-Nancy, 54511, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: from date of initial bile sample up to 30 days of postoperative period
bacterial count in log10 bacteria/ml and identification
Time frame: from date of initial bile sampling to date of surgery (up to 90 days)
bacterial count in log10 bacteria/ml and species identification
Time frame: from date of initial bile sample up to 90 postoperative days
bacterial count in log10 bacteria/ml and species identification
Time frame: from date of surgery up to 30 postoperative days
Clavien-Dindo Classification, SOFA score
Time frame: During hospital stay (up to 90 days after surgery)
number of event occurence
Time frame: During hospital stay (up to 90 days after surg
incidence in percentage
Time frame: During the ICU stay and hospital
Number of days in ICU and hospital
Time frame: At day +28 and day +90
number of death at 28 days and 90 days
Time frame: from date of initial bile sample up to 30 days of postoperative period
Parenteral, enteral, oral feeding in days and calories
Time frame: preoperative
Body mass index (BMI) and albuminemia computation
Central Hospital, Nancy, France
Other
Colonization of Bile Ducts and Post-operative Infectious Complications of Cephalic Duodenopancreatectomy : A Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02992951
Bacterial Infections, Bacterial Infections and Mycoses
Hull, East Riding of Yorkshire, United Kingdom
View Trial DetailsNCT05960006
Antibiotic Toxicity, Ascites Hepatic
Amsterdam, Netherlands
View Trial DetailsNCT04894500
Bacterial Infections, Bacterial Infections and Mycoses
Prague, Czechia
View Trial DetailsNCT03163628
Bacterial Infections, Bacterial Infections and Mycoses
Bron, France
View Trial Details